The prevalence and characteristics of MCCB cognitive impairment in unmedicated patients with bipolar II depression and major depressive disorder

Shunkai Lai,Shuming Zhong,Ying Wang,Yiliang Zhang,Ying Xue,Hui Zhao,Hanglin Ran,Shuya Yan,Yange Luo,Jiali He,Yunxia Zhu,Sihui Lv,Zijing Song,Haofei Miao,Yilei Hu,Xiaosi Huang,Xiaodan Lu,Jiansong Zhou,Yanbin Jia
DOI: https://doi.org/10.1016/j.jad.2022.04.153
IF: 6.533
2022-04-01
Journal of Affective Disorders
Abstract:BackgroundCognitive impairment has been acknowledged as a core clinical manifestation of bipolar disorder (BD) as well as major depressive disorder (MDD). Determining the prevalence and characteristics of cognitive impairment is important for clinical interventions. This study investigated the prevalence and characteristics of cognitive impairment based on the Measurement and Treatment Research to Improve Cognition Schizophrenia Consensus Cognitive Battery (MCCB) in both BD and MDD.MethodOne hundred and forty-nine BD II depression, 147 MDD, and 124 demographically matched healthy controls (HCs) underwent MCCB cognitive assessment. The prevalence of MCCB cognitive impairment and group comparisons were performed. Additionally, association analysis was performed to investigate the relationship between cognitive performance and clinical variables.ResultsCompared to the HCs group, both BD II depression and MDD groups had a significantly reduced performance for all MCCB (all p < 0.05). The numerical scores for visual learning were lower in the BD II depression group compared to the MDD group. 32.89% of the BD II depression patients had clinically significant impairment (>1.5 SD below the normal mean) in two or more domains compared to 23.13% for MDD patients (p = 0.363).ConclusionsA high percent of patients in the BD II depression or MDD group exhibited MCCB cognitive impairments with clinical significance. Cognitive impairments were more common in BD II compared to MDD patients, particularly for visual learning. These findings suggest that clinicians should be aware of the severe cognitive impairment in mood disorders and establish effective cognitive screening and intervention strategies.
psychiatry,clinical neurology
What problem does this paper attempt to address?